Type 2 diabetes

No abstract is available for this paper.

• Publication year

  2017

• Venue

  The Lancet

• Publication date

  2017-06-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/S0140-6736(17)30058-2PMID 28190580
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Natriuretic Peptide and High-Sensitivity Troponin for Cardiovascular Risk Prediction in Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

  2016cited by this paper
• Expanding Treatment Options for Youth With Type 2 Diabetes: Current Problems and Proposed Solutions

  2016cited by this paper
• Future glucose-lowering drugs for type 2 diabetes.

  2016cited by this paper
• Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participants

  2016cited by this paper
• First Clinical Experience with Retrospective Flash Glucose Monitoring (FGM) Analysis in South Africa

  2016cited by this paper
• Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes.

  2016cited by this paper
• Cardiovascular Risk Factor Targets and Cardiovascular Disease Event Risk in Diabetes: A Pooling Project of the Atherosclerosis Risk in Communities Study, Multi-Ethnic Study of Atherosclerosis, and Jackson Heart Study

  2016cited by this paper
• Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.

  2016cited by this paper
• The incretin effect in healthy individuals and those with type 2 diabetes: physiology, pathophysiology, and response to therapeutic interventions.

  2016cited by this paper
• Rates and predictors of hypoglycaemia in 27 585 people from 24 countries with insulin‐treated type 1 and type 2 diabetes: the global HAT study

  2016cited by this paper
• Effects of multiple ascending doses of the glucagon receptor antagonist PF‐06291874 in patients with type 2 diabetes mellitus

  2016cited by this paper
• The Time Is Right for a New Classification System for Diabetes: Rationale and Implications of the β-Cell–Centric Classification Schema

  2016cited by this paper
• Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin

  2016cited by this paper
• Type 2 Diabetes Genetic Predisposition, Obesity, and All-Cause Mortality Risk in the U.S.: A Multiethnic Analysis

  2016cited by this paper
• Management of obesity.

  2016cited by this paper
• Human umbilical cord‐derived mesenchymal stem cells elicit macrophages into an anti‐inflammatory phenotype to alleviate insulin resistance in type 2 diabetic rats

  2016cited by this paper
• Benefits and Harms of Once-Weekly Glucagon-like Peptide-1 Receptor Agonist Treatments

  2016cited by this paper
• Pioglitazone use and risk of bladder cancer: population based cohort study

  2016cited by this paper
• Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials

  2016cited by this paper
• Role of Glycated Proteins in the Diagnosis and Management of Diabetes: Research Gaps and Future Directions

  2016cited by this paper
• Very Low-Calorie Diet and 6 Months of Weight Stability in Type 2 Diabetes: Pathophysiological Changes in Responders and Nonresponders

  2016cited by this paper
• Long-term Benefits of Intensive Glucose Control for Preventing End-Stage Kidney Disease: ADVANCE-ON

  2016cited by this paper
• Continuous Glucose Monitoring in the Self-management of Type 2 Diabetes: A Paradigm Shift

  2016cited by this paper
• Global, regional, and national incidence, prevalence, and years lived with disability for 310 diseases and injuries, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015

  2016cited by this paper
• Restoring normoglycaemia by use of a very low calorie diet in long‐ and short‐duration Type 2 diabetes

  2015cited by this paper
• Diabetes in older people: new insights and remaining challenges.

  2015cited by this paper
• Update on Prevention of Cardiovascular Disease in Adults With Type 2 Diabetes Mellitus in Light of Recent Evidence: A Scientific Statement From the American Heart Association and the American Diabetes Association

  2015cited by this paper
• Pioglitazone Use and Risk of Bladder Cancer and Other Common Cancers in Persons With Diabetes.

  2015cited by this paper
• An observational study of patient characteristics and mortality following hypoglycemia in the community

  2015cited by this paper
• Euglycemic Diabetic Ketoacidosis: A Potential Complication of Treatment With Sodium–Glucose Cotransporter 2 Inhibition

  2015cited by this paper
• Transcriptomics in type 2 diabetes: Bridging the gap between genotype and phenotype

  2015cited by this paper
• Systematic Review and Meta-Analysis of Response Rates and Diagnostic Yield of Screening for Type 2 Diabetes and Those at High Risk of Diabetes

  2015cited by this paper
• Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical Trial.

  2015cited by this paper
• Reversal of Type 2 diabetes after bariatric surgery is determined by the degree of achieved weight loss in both short‐ and long‐duration diabetes

  2015cited by this paper
• A Type 1 Diabetes Genetic Risk Score Can Aid Discrimination Between Type 1 and Type 2 Diabetes in Young Adults

  2015cited by this paper
• OPTIMIZED HUMAN REGULAR U-500 INSULIN TREATMENT IMPROVES β-CELL FUNCTION IN SEVERELY INSULIN-RESISTANT PATIENTS WITH LONG-STANDING TYPE 2 DIABETES AND HIGH INSULIN REQUIREMENTS.

  2015cited by this paper
• Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes.

  2015cited by this paper
• New Insulins and New Aspects in Insulin Delivery.

  2015cited by this paper
• Radically upgrading diabetes prevention in England.

  2015cited by this paper
• Minimizing Hypoglycemia in Diabetes

  2015cited by this paper
• Potential overtreatment of diabetes mellitus in older adults with tight glycemic control.

  2015cited by this paper
• Moving towards a more precise treatment of diabetes.

  2015cited by this paper
• The Economic Costs of Type 2 Diabetes: A Global Systematic Review

  2015cited by this paper
• Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials.

  2015cited by this paper
• Excess Mortality among Persons with Type 2 Diabetes.

  2015cited by this paper
• Long-term Effects of Lifestyle Intervention or Metformin on Diabetes Development and Microvascular Complications: the DPP Outcomes Study

  2015cited by this paper
• GLP-1 receptor agonists: a review of head-to-head clinical studies

  2015cited by this paper
• Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer

  2015cited by this paper
• The role of the kidneys in glucose homeostasis in type 2 diabetes: clinical implications and therapeutic significance through sodium glucose co-transporter 2 inhibitors.

  2014cited by this paper
• Rates of complications and mortality in older patients with diabetes mellitus: the diabetes and aging study.

  2014cited by this paper
• Regression From Prediabetes to Normal Glucose Regulation Is Associated With Reduction in Cardiovascular Risk: Results From the Diabetes Prevention Program Outcomes Study

  2014cited by this paper
• Investigational new insulin glargine 300 U/ml has the same metabolism as insulin glargine 100 U/ml

  2014cited by this paper
• Long‐term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial

  2014cited by this paper
• Metformin—mode of action and clinical implications for diabetes and cancer

  2014cited by this paper
• Glycemic Goals in Diabetes: Trade-off Between Glycemic Control and Iatrogenic Hypoglycemia

  2014cited by this paper
• ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD – Summary

  2014cited by this paper
• Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial.

  2014cited by this paper
• Prevention of type 2 diabetes; a systematic review and meta‐analysis of different intervention strategies

  2014cited by this paper
• Genetic susceptibility to type 2 diabetes and obesity: from genome-wide association studies to rare variants and beyond

  2014cited by this paper
• Sulfonylurea versus metformin monotherapy in patients with type 2 diabetes: a Cochrane systematic review and meta-analysis of randomized clinical trials and trial sequential analysis.

  2014cited by this paper
• Effect of a long-term behavioural weight loss intervention on nephropathy in overweight or obese adults with type 2 diabetes: a secondary analysis of the Look AHEAD randomised clinical trial.

  2014cited by this paper
• A meta‐analysis of the hypoglycaemic risk in randomized controlled trials with sulphonylureas in patients with type 2 diabetes

  2014cited by this paper
• Glucagon-like peptide-1 receptor agonist and basal insulin combination treatment for the management of type 2 diabetes: a systematic review and meta-analysis

  2014cited by this paper
• Metformin in patients with type 2 diabetes and kidney disease: a systematic review.

  2014cited by this paper
• Impact of Intensive Lifestyle Intervention on Depression and Health-Related Quality of Life in Type 2 Diabetes: The Look AHEAD Trial

  2014cited by this paper
• A rationally designed monomeric peptide triagonist corrects obesity and diabetes in rodents

  2014cited by this paper
• Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes.

  2014cited by this paper
• Diabetes Prevention in the Real World: Effectiveness of Pragmatic Lifestyle Interventions for the Prevention of Type 2 Diabetes and of the Impact of Adherence to Guideline Recommendations

  2014cited by this paper
• Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus.

  2013cited by this paper
• Results of a reevaluation of cardiovascular outcomes in the RECORD trial.

  2013cited by this paper
• Complementing Insulin Therapy to Achieve Glycemic Control

  2013cited by this paper
• Effect of Intensive Lifestyle Intervention on Sexual Dysfunction in Women With Type 2 Diabetes

  2013cited by this paper
• A Critical Analysis of the Clinical Use of Incretin-Based Therapies

  2013cited by this paper
• Alogliptin after acute coronary syndrome in patients with type 2 diabetes.

  2013cited by this paper
• Clinical Inertia in People With Type 2 Diabetes

  2013cited by this paper
• Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes.

  2013cited by this paper
• Rationale and Design of the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)

  2013cited by this paper
• SGLT inhibitors in management of diabetes.

  2013cited by this paper
• Real‐world factors affecting adherence to insulin therapy in patients with Type 1 or Type 2 diabetes mellitus: a systematic review

  2013cited by this paper
• Weight maintenance and additional weight loss with liraglutide after low-calorie-diet-induced weight loss: The SCALE Maintenance randomized study

  2013cited by this paper
• Diabetes and Driving

  2013cited by this paper
• Long-Term Complications and Mortality in Young-Onset Diabetes

  2013cited by this paper
• Hypoglycemia and Diabetes: A Report of a Workgroup of the American Diabetes Association and The Endocrine Society

  2013cited by this paper
• Bariatric surgery versus conventional medical therapy for type 2 diabetes.

  2012cited by this paper
• A clinical trial to maintain glycemic control in youth with type 2 diabetes.

  2012cited by this paper
• Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)

  2012cited by this paper
• Systematic Assessment of Etiology in Adults With a Clinical Diagnosis of Young-Onset Type 2 Diabetes Is a Successful Strategy for Identifying Maturity-Onset Diabetes of the Young

  2012cited by this paper
• Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial.

  2012cited by this paper
• Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial

  2012cited by this paper
• Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis.

  2012cited by this paper
• Effectiveness of a diabetes education and self management programme (DESMOND) for people with newly diagnosed type 2 diabetes mellitus: three year follow-up of a cluster randomised controlled trial in primary care

  2012cited by this paper
• Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline.

  2011cited by this paper
• The Possible Protective Role of Glucagon-Like Peptide 1 on Endothelium During the Meal and Evidence for an “Endothelial Resistance” to Glucagon-Like Peptide 1 in Diabetes

  2011cited by this paper
• Screening for diabetes using an oral glucose tolerance test within a western multi-ethnic population identifies modifiable cardiovascular risk: the ADDITION-Leicester study

  2011cited by this paper
• Insulin detemir versus insulin glargine for type 2 diabetes mellitus.

  2011cited by this paper
• Dapagliflozin Versus Glipizide as Add-on Therapy in Patients With Type 2 Diabetes Who Have Inadequate Glycemic Control With Metformin

  2011cited by this paper
• Effects of Rosiglitazone, Glyburide, and Metformin on β-Cell Function and Insulin Sensitivity in ADOPT

  2011cited by this paper
• Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus.

  2010cited by this paper
• Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis

  2010cited by this paper
• Clinical inertia in management of T2DM.

  2010cited by this paper

• [Cross-regulation between olfaction and energy homeostasis in obesity and type 2 diabetes: from mouse models to humans].

  2026cites this paper
• Nailfold capillaroscopy for early detection of diabetic retinopathy: A non-invasive window into microvascular abnormalities

  2026cites this paper
• New multitarget antidiabetic potential agents based on sulfaguanidine: design, synthesis, and biological evaluation

  2026cites this paper
• Advancement in peptide-based therapeutics for the treatment of type 2 diabetes mellitus: current progress and future prospects.

  2026cites this paper
• Troxerutin, a herbal metabolite with antidiabetic and antihypercholesterolemic potential, regulates metabolic gene activity in male diabetic rats

  2026cites this paper
• Sex differences in trial representation and the cardiovascular effectiveness of newer glucose‐lowering agents in patients with and without type 2 diabetes: A systematic review and meta‐analysis of cardiovascular outcome trials

  2026cites this paper
• Local administration of low-intensity vibration improves wound healing in diabetic mice.

  2026cites this paper
• Gut Microbiota and Type 2 Diabetes: Genetic Associations, Biological Mechanisms, Drug Repurposing, and Diagnostic Modeling

  2026cites this paper
• Impact of patient-centred care and population health management on diabetes and hypertension outcomes

  2026cites this paper
• Effects of crude polysaccharides from Coix seeds fermented by Limosilactobacillus reuteri on hyperglycemia and gut microbiota in type 2 diabetic mice

  2026cites this paper
• A comprehensive review and meta-analysis of relationship between age of onset or duration of type 2 diabetes and mortality involving more than 2.85 million patients.

  2026cites this paper
• Mortality and Cumulative Cardiovascular Risk Factor Control in Patients with Type 2 Diabetes: A Nationwide Population-Based Cohort Study.

  2026cites this paper
• Effect of diabetes self-management education in type 2 diabetes management - a systematic umbrella review of meta-analysis.

  2026cites this paper
• The epidemiology of metabolic dysfunction-associated steatotic liver disease among pediatric patients with type 2 diabetes: Systematic review and meta-analysis

  2026cites this paper
• Psychological flexibility patterns in patients with type 2 diabetes mellitus and its associations with self-care behavior and medical condition

  2026cites this paper
• Molecular engineering of designer diabetes therapeutics.

  2026cites this paper
• Exercise-Associated Changes in Body Composition and Metabolic Biomarkers Following an Eight-Week Submaximal Exercise Program in Women Across Different BMI Categories and with Type 2 Diabetes.

  2026cites this paper
• Early detection of type 2 diabetes mellitus-associated cognitive dysfunction: The potential of amide proton transfer-weighted imaging.

  2026cites this paper
• Hydroalcoholic extract of Benincasa hispida (Thunb.) Cogn. reinstates renal structural and functional dynamics compromised in diabetic mice: molecular insights through integration of transcriptomics and proteomics.

  2026cites this paper
• Association between serum spexin levels and diabetic nephropathy in patients with type 2 diabetes: a cross-sectional study

  2025cites this paper
• Arabinoxylan Concentrate from Wheat as a Functional Food Ingredient to Improve Glucose Homeostasis

  2025cites this paper
• Quercetin Enhances GLP‐1 Secretion via TAS2R38‐Mediated PLC Signaling in Enteroendocrine L‐Cells

  2025cites this paper
• Comparative efficacy of various mind-body exercise types on cardiometabolic health in patients with type 2 diabetes: a network meta-analysis of randomized controlled trials

  2025cites this paper
• Jejunoileal side-to-side anastomosis: New hope for patients with type 2 diabetes?

  2025cites this paper
• Impact of SGLT-2i on COPD Exacerbations in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis.

  2025cites this paper
• Highlighted gene expression alteration in human pancreatic isolated islets in patients with type 2 diabetes

  2025cites this paper
• Profile of Serum Bile Acids in Elderly Type 2 Diabetic Patients with Various Obesity Types: A Cross-Sectional Study

  2025cites this paper
• Molecular Mechanisms and Therapeutic Perspectives of Luteolin on Diabetes and Its Complications.

  2025cites this paper
• Trajectories of metabolic risk factors prior to the onset of cardiovascular disease in patients with newly diagnosed diabetes.

  2025cites this paper
• The Causal Effect of Basal Metabolic Rate on Type 2 Diabetes: A Two-Sample Mendelian Randomization Study

  2025cites this paper
• Clinical use of polygenic scores in type 2 diabetes: challenges and possibilities

  2025cites this paper
• Image Classification and Segmentation for Estimating Calories of Food

  2025influential citation
• Bridging illness uncertainty and self-care: The role of cognitive emotion regulation in type 2 diabetes management.

  2025cites this paper
• Incidence, prevalence, and burden of type 2 diabetes in China: Trend and projection from 1990 to 2050

  2025cites this paper
• Understanding the peroxisome proliferator-activated receptor gamma (PPAR-γ) role in periodontitis and diabetes mellitus: A molecular perspective.

  2025cites this paper
• Integrated Phenotypic and Transcriptomic Analyses of Osteoporosis in Type 2 Diabetic Mice

  2025cites this paper
• Accelerometer-derived physical activity patterns and incident type 2 diabetes: a prospective cohort study

  2025cites this paper
• Protein S-acylation: Pathological mechanisms and novel therapeutic targets for diabetic complications

  2025cites this paper
• Astragalus Polysaccharides Ameliorate Diabetic Bladder Dysfunction via Normalization of Neuromuscular Conduction

  2025cites this paper
• Integrated in vitro, in silico, and in vivo approaches to elucidate the antidiabetic mechanisms of Cicer arietinum and Hordeum vulgare extract and secondary metabolites

  2025cites this paper
• Influencia de los factores socioeconómicos en la prevalencia de la diabetes mellitus tipo 2 en Catalunya

  2025cites this paper
• Molecular glues of the regulatory ChREBP/14-3-3 complex protect beta cells from glucolipotoxicity

  2025cites this paper
• The Role of Yes‐Associated Protein in Inflammatory Diseases and Cancer

  2025cites this paper
• Advances in incretin therapies for targeting cardiovascular disease in diabetes.

  2025cites this paper
• Antidiabetic Drugs Consumption in France Over a Decade: An Observational Study.

  2025cites this paper
• Aerobic Exercise and Cardiovascular Outcomes in Patients with Diabetes Undergoing Percutaneous Coronary Intervention: A Nationwide Population-based Study.

  2025cites this paper
• Investigating the non‐linear association between sleep duration and type 2 diabetes: conventional and Mendelian randomization analyses from the UK Biobank

  2025cites this paper
• Regulating effect of serum selenium on diabetic kidney disease related all-cause mortality: evidence from NHANES database

  2025cites this paper
• Management of alveolar osteitis: new regenerative techniques in patients with type 2 diabetes

  2025cites this paper
• Diabetes Mellitus and Cognitive Decline: A Systematic Review Exploring the Link to Dementia and Neurodegenerative Diseases

  2025cites this paper
• Advances in artificial intelligence for diabetes prediction: insights from a systematic literature review

  2025cites this paper
• Association between the plasma atherogenic index and type 2 diabetes in Chinese population: prospective cohort study based on 4C study.

  2025cites this paper
• Saliva insulin concentration following ingestion of a standardized mixed meal tolerance test: Influence of obesity status.

  2025cites this paper
• Exploration of novel dipeptidyl peptidase-IV inhibitory tetrapeptide from walnut (Juglans sigillata) protein and its effect on diabetes-like phenotypes induced by high-sugar diet in Drosophila melanogaster.

  2025cites this paper
• Decoding TMAO in the Gut-Organ Axis: From Biomarkers and Cell Death Mechanisms to Therapeutic Horizons

  2025cites this paper
• Type-2 diabetes epigenetic biomarkers: present status and future directions for global and Indigenous health

  2025cites this paper
• Sociodemographic and Lifestyle Factors Associated with Undiagnosed Diabetes in Indonesia: Findings from the Basic Health Research Work of Riskesdas 2018

  2025cites this paper
• Self-care activities mediate self-perceived burden and depression in Chinese patients with type 2 diabetes

  2025cites this paper
• Comparative efficacy and safety of SGLT2 inhibitor class members in patients with heart failure and type 2 diabetes: A systematic review and network meta-analysis of randomized controlled trials.

  2025cites this paper
• Relationships between atherogenic index of plasma and body mass index with the risk of type 2 diabetes mellitus: insights from CHARLS

  2025cites this paper
• Assessment of Hepatoprotective and Nephroprotective potentials of a Novel Anti-diabetic Poly Herbal Preparation

  2025cites this paper
• Epigallocatechin gallate prevents and alleviates type 2 diabetes mellitus (T2DM) through gut microbiota and multi-organ interactions in Wistar healthy rats and GK T2DM rats

  2025influential citation
• Aerobic exercise improves inflammation and insulin resistance in skeletal muscle by regulating miR-221-3p via JAK/STAT signaling pathway

  2025cites this paper
• White Matter Microstructural Alterations in Type 2 Diabetes: A Combined UK Biobank Study of Diffusion Tensor Imaging and Neurite Orientation Dispersion and Density Imaging

  2025cites this paper
• Association of the triglyceride glucose index with sudden cardiac death in the patients with diabetic foot ulcer.

  2025cites this paper
• A systematic review & updated meta-analysis on the association between higher consumption of ultra processed foods and risk of diabetes and its complications: Response letter.

  2025cites this paper
• Morroniside restrains renal glucose reabsorption to regulate glucose metabolism via the PPARδ/SGLT2 signaling pathway.

  2025cites this paper
• A randomized multi-arm open labelled comparative clinical trial report of Pankajakasthuri DiabetEaze powder, a novel polyherbal formulation on the nutritional management and glycemic control in type 2 diabetic and prediabetic patients

  2025cites this paper
• A noval neuro-biomarker of cognitive impairment related to cerebral small vessel disease in patients with T2DM: Lenticulostriate arteries

  2025cites this paper
• Integrated Approach for Biomarker Discovery and Mechanistic Insights into the Co-Pathogenesis of Type 2 Diabetes Mellitus and Non-Hodgkin Lymphoma

  2025cites this paper
• Microvessel co-transplantation improves poor remuscularization by hiPSC-cardiomyocytes in a complex disease model of myocardial infarction and type 2 diabetes

  2025cites this paper
• Cultural Aspects of Type-2 Diabetes-related Social Stigma: A Cultural Epidemiological Study among General Community Members in Urban Pune, India

  2025cites this paper
• Genetic Variants of SLC22A1 rs628031 and rs622342 and Glycemic Control in T2DM Patients from Northern Mexico

  2025cites this paper
• Socio-demographic and clinical determinants of self-care in adults with type 2 diabetes: a multicenter cross-sectional study in Zhejiang province, China

  2025cites this paper
• Adipose tissue-derived microRNA-450a-5p induces type 2 diabetes mellitus by downregulating DUSP10

  2025cites this paper
• Noninvasive hemodynamic assessment of type 2 diabetes mellitus using four-dimensional flow magnetic resonance imaging

  2025cites this paper
• PCK1 and SLC22A2 gene variants associated with response to metformin treatment in type 2 diabetes

  2025cites this paper
• The application of procyanidins in diabetes and its complications: a review of preclinical studies

  2025cites this paper
• Glucagon-like peptide 1 (GLP-1) receptor agonists for people with chronic kidney disease and diabetes.

  2025cites this paper
• Global, regional, and national burden of diabetes and its risk factors in women of child-bearing age, from 1990 to 2021.

  2025cites this paper
• Association of SIRT1 rs3758391 Polymorphism With T2DM in Bangladeshi Population: Evidence From a Case‐Control Study and Meta‐Analysis

  2025cites this paper
• Prospective associations between muscle strength and genetic susceptibility to type 2 diabetes with incident type 2 diabetes: a UK Biobank study

  2025cites this paper
• Sulfated Glycosaminoglycan CIP-3 from Edible Marine Octopus Cistopus indicus: A Promising Bioactive with Anti-Hyperglycemic Effects in 3T3-L1 Adipocyte Cells for Functional Food Applications

  2025cites this paper
• Chronic Inflammation and Glycemic Control: Exploring the Bidirectional Link Between Periodontitis and Diabetes

  2025cites this paper
• Gestational hyperglycaemia impacts glucose control and insulin sensitivity in mouse offspring

  2025cites this paper
• Importance of assessing erectile dysfunction in patients with type 2 diabetes mellitus based on glucose fluctuation: a Cross-Sectional study

  2025cites this paper
• Healthcare workers’ perspectives on barriers and facilitators to referral to type 2 diabetes prevention programmes: a systematic review

  2025cites this paper
• Per- and polyfluoroalkyl substances and type 2 diabetes among older adults: Synthesizing cross-sectional population study and meta-analysis.

  2025cites this paper
• Discovery and identification of semaphorin 4D as a bioindicator of high fracture incidence in type 2 diabetic mice with glucose control

  2025cites this paper
• Medication time of metformin and sulfonylureas and incidence of cardiovascular diseases and mortality in type 2 diabetes: a pooled cohort analysis

  2025cites this paper
• Effects of Lifestyle Interventions to Promote Physical Activity on Physical Activity and Glycated Hemoglobin in Patients with Type 2 Diabetes: a Systematic Review and Meta-Analysis

  2025cites this paper
• Polysaccharide from Momordica charantia L. Alleviates Type 2 Diabetes Mellitus in Mice by Activating the IRS1/PI3K/Akt and AMPK Signaling Pathways and Regulating the Gut Microbiota.

  2025cites this paper
• Social determinants of health and type 2 diabetes in Asia

  2025cites this paper
• Association between type 2 diabetes and binge eating disorder.

  2025cites this paper
• Socioeconomic Status, Modifiable Factors, and Risk of Microvascular Complications in Individuals With Type 2 Diabetes: A Cohort Study From the UK Biobank

  2025cites this paper
• Understanding the Unmet Needs of People Living with Type 2 Diabetes in Self-Managing Their Condition

  2025cites this paper
• Food Phytochemicals as Epigenetic Modulators in Diabetes: A Systematic Review

  2025cites this paper
• Effect of Triphalakatakanpathadi Kashaya on glycaemic control and Quality of Life in Type 2 Diabetes Mellitus in Sri Lankan Population - A Descriptive Observational Study

  2025cites this paper
• Linagliptin-Loaded Bilosomes for Oral Administration: Formulation, Optimization by Box-Behnken Design, In-vitro, and In-vivo Assessment

  2025cites this paper
• Association of accelerated phenotypic aging, genetic risk, and lifestyle with progression of type 2 diabetes: a prospective study using multi-state model

  2025cites this paper